ScripsAmerica Inc. logo

ScripsAmerica Inc. (SCRCQ)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
14.11K Market Cap
- P/E Ratio
- Div Yield
125 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track SCRCQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SCRCQ closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, SCRCQ stock gained 0%.
SCRCQ is not paying dividends to its shareholders.
The last earnings report, released on Feb 28, 2024, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0033%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

SCRCQ Chart

People also search for

Decker Manufacturing Corporation
$ 57.01
0%
Cannabix Technologies Inc.
$ 0.38
-1.8088%
VicapSys Life Sciences Inc.
$ 1.45
0%
Nuo Therapeutics Inc.
$ 0.85
0%
Quantumzyme Corp.
$ 0.8
+33.3333%

ScripsAmerica Inc. (SCRCQ) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

ScripsAmerica Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is SCRCQ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 14.11K.

Has ScripsAmerica Inc. ever had a stock split?

No, there has never been a stock split.

ScripsAmerica Inc. Profile

Pharmaceuticals Industry
Healthcare Sector
Brian Ettinger CEO
OTC PINK Exchange
811066109 CUSIP
US Country
21 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

ScripsAmerica, Inc., founded in 2008 and headquartered in Clifton, New Jersey, embarked on developing and distributing non-sterile topical and transdermal pain creams. Over the years, the company broadened its scope to include pharmacy dispensing services tailored for individual doctors, in addition to offering billing and administrative support to independent pharmacies. Moreover, ScripsAmerica played a pivotal role in the pharmaceutical supply chain by distributing products to independent pharmacies and various medical providers. Nonetheless, the company faced financial difficulties, filing for Chapter 11 bankruptcy on September 7, 2016. Subsequently, its petition for reorganization under Chapter 11 was converted to Chapter 7 on February 8, 2017, marking the end of its operational activities.

Products and Services

  • Non-sterile Topical and Transdermal Pain Creams

    ScripsAmerica developed a line of non-sterile pain management products, including topical and transdermal creams. These products were designed to provide patients with relief from various types of pain without the need for oral medications, targeting the discomfort directly at its source.

  • Pharmacy Dispensing Services

    The company offered specialized dispensing services, catering specifically to the needs of individual healthcare providers. This service aimed to streamline the prescription process, ensuring that physicians could directly provide patients with necessary medications, thereby enhancing the efficiency and personalization of treatment.

  • Billing and Administrative Services

    ScripsAmerica extended its services to aid independent pharmacies with billing and administrative tasks. This support was crucial in reducing the operational burden on pharmacies, allowing them to focus more on patient care and less on administrative complexities.

  • Distribution of Pharmaceutical Products

    Understanding the needs of independent pharmacies and medical providers, ScripsAmerica also operated as a distributor of pharmaceutical products. This role was vital in ensuring that these entities had access to a wide range of medications, thereby enhancing their ability to cater to the diverse needs of their patients.

Contact Information

Address: 1094 Main Avenue
Phone: 800-957-7622